[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gandossi et al., 1998 - Google Patents

Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors

Gandossi et al., 1998

Document ID
18405881798869630842
Author
Gandossi E
Lunven C
Gauffeny C
Roome N
Berry C
Publication year
Publication venue
Thrombosis and haemostasis

External Links

Snippet

The activation of rabbit platelets by rabbit plasma clots, and the inhibition of clot-associated thrombin by heparin: antithrombin III, recombinant hirudin (rHV2Lys47) and argatroban, a low molecular weight thrombin inhibitor, was studied. Plasma clots caused the aggregation …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

Similar Documents

Publication Publication Date Title
Berry et al. Effects of the synthetic thrombin inhibitor argatroban on fibrin-or clot-incorporated thrombin: comparison with heparin and recombinant hirudin
Koppelman et al. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII
Moore et al. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.
Downing et al. Comparison of the inhibition of thrombin by three plasma protease inhibitors
Nawroth et al. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.
Kumar et al. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity
España et al. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease
Herault et al. Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinase
US5847085A (en) Modified protein C and methods of use thereof
US4364861A (en) Blood-coagulation-promoting products and methods of preparing them
Hedner et al. Determination of plasminogen in clots and thrombi
Gandossi et al. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors
De Fouw et al. The influence of thrombin and platelets on fibrin clot lysis rates in vitro: a study using a clot lysis system consisting of purified human proteins
Matsumoto et al. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses
Khan et al. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass
Green et al. In vitro studies of a new synthetic thrombin inhibitor
Steiner et al. Kinetic studies of the role of monovalent cations in the amidolytic activity of activated bovine plasma protein C
JPH04293500A (en) Reagent for determining viii factor activity
Liu et al. Thrombin binding to platelets and their activation in plasma
Fay et al. Effects of radiographic contrast agents on thrombin formation and activity
Hultin Studies of factor IX concentrate therapy in hemophilia
Machovich Choices among the possible reaction routes catalyzed by thrombin
Markwardt et al. Influence of thrombin inhibitors on the thrombin-induced activation of human blood platelets
Hijikata-Okunomiya et al. Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III
Travis et al. Proteolytic enzymes and platelets in relation to blood coagulation